͵¿úÖ±²¥

Skip to Main ContentSkip to FooterSkip to Search
Main menu
Regional Sites
  1. Home
  2.  » 
  3. Oral Dose
  4.  » 
  5. Development & Bioavailability
  6.  » Preclinical Development

PRECLINICAL DEVELOPMENT

Moving More Molecules into Development

PRECLINICAL DEVELOPMENT

Thousands of drug candidates are abandoned annually due to solubility and bioavailability issues, but advanced formulation technologies can profoundly impact ADME and improve the fate of many of these candidates, improving PK profiles and PD responses.

With specialized capabilities and experience, ͵¿úÖ±²¥ offers comprehensive evaluations of compounds from formulation through preclinical in vivo proof-of-concept and can provide you with preclinical formulations to help you move more molecules from discovery to development.

By using this website you understand and accept that ͵¿úÖ±²¥ tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Ìý´¥ÌýÌý´¥ÌýCookies Settings.